Effects of extra virgin olive oil and fish oil on lipid profile and oxidative stress in patients with metabolic syndrome

Nutrition

Volumn 31, Issue 6, 2015, Pages 834-840

  Venturini, Danielle ^a   Simão, Andréa Name Colado ^a   Urbano, Mariana Ragassi ^a   Dichi, Isaias ^a  

^a UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

Fish oil; Lipid profile; Metabolic syndrome; Olive oil; Oxidative stress

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; CHOLESTEROL; FISH OIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROPEROXIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OLIVE OIL; OMEGA 3 FATTY ACID; PEROXY RADICAL; URIC ACID; ANTIOXIDANT; PEROXIDE;

ADULT; ARTICLE; BRAZIL; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FAT INTAKE; FEMALE; HUMAN; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZATION; UNIVERSITY HOSPITAL; BLOOD; CHEMISTRY; DIET THERAPY; DRUG EFFECTS; DRUG POTENTIATION; MIDDLE AGED; OLIVE TREE; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTIOXIDANTS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DRUG SYNERGISM; FATTY ACIDS, OMEGA-3; FEMALE; FISH OILS; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OLEA; OLIVE OIL; OXIDATIVE STRESS; PEROXIDES;

EID: 84928543540     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2014.12.016     Document Type: Article

References (56)

1. Eckel R.H., Alberti K.G.M.M., Grundy S.M., Zimmet P.Z. The metabolic syndrome. Lancet 2010, 375:181-183.
2. Venturini D., Simão A.N., Scripes N.A., Bahls L.D., Melo P.A.S., Belinetti F.M., et al. Evaluation of oxidative stress in overweight subjects with or without metabolic syndrome. Obesity 2012, 20:2361-2366.
3. Estruch R., Ros E., Salas-Salvadó J., Covas M.I., Corella D., Arós F., et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013, 368:1279-1290.
4. Kastorini C.M., Milionis H.J., Esposito K., Giugliano D., Goudevenos G.A., Panagiotakos D.B. The effect of Mediterranean diet on metabolic syndrome and its components. J Am Coll Cardiol 2011, 57:1299-1313.
5. Buckland G., Agudo A., Travier N., María Huerta J., Cirera L., Tormo M.J., et al. Adherence to the Mediterranean diet reduces mortality in the Spanish cohort of the European Prospective Investigation into cancer and nutrition. Br J Nutr 2011, 106:1581-1591.
6. Minich D.M., Bland J.S. Dietary management of the metabolic syndrome beyond macronutrients. Nutr Rev 2008, 66:429-444.
7. Barzi F., Woodward M., Marfisi R.M., Tavazzi L., Valagussa F., Marchioli R. Mediterranean diet and all-causes mortality after myocardial infarction: results from the GISSI- Prevenzione trial. Eur J Clin Nutr 2003, 57:604-611.
8. Perez-Jimenez F., Ruano J., Perez-Martinez P., Lopez-Segura F., Lopez-Miranda J. The influence of olive oil on human health: not a question of fat alone. Mol Nutr Food Res 2007, 51:1199-1208.
9. Carluccio M.A., Massaro M., Scoditti E., De Caterina R. Vasculoprotective potential of olive oil components. Mol Nutr Food Res 2007, 51:1225-1234.
10. Estruch R., Martinez-Gonzalez M.A., Corella D., Salas-Salvado J., Ruiz-Gutierrez V., Covas M.I., et al. Effects of a Mediterranean style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med 2006, 145:1-11.
11. Vincent-Baudry S., Defoord C., Gerber M., Bernard M.C., Verger P., Helal O., et al. The Medi-RIVAGE study: reduction of cardiovascular disease risk after a 3-mo intervention with a Mediterranean-type diet or a low-fat diet. Am J Clin Nutr 2005, 82:964-971.
12. Ruano J., Lopez-Miranda J., Fuentes F., Moreno J.A., Bellido C., Perez-Martinez P., et al. Phenolic content of virgin olive oil improves ischemic reactive hyperemia in hypercholesterolemic patients. J Am Coll Cardiol 2005, 46:1864-1868.
13. Bondia-Pons I., Schroder H., Covas M.I., Castellote A.L., Kaikkonen J., Poulsen H.E., et al. Moderate consumption of olive oil by healthy European men reduces systolic blood pressure in non-Mediterranean participants. JNutr 2007, 137:84-87.
14. Yashodhara B.M., Umakanth S., Pappachan J.M., Bhat S.K., Kamath R., Choo B.H. Omega-3 fatty acids: a comprehensive review of their role in health and disease. Postgrad Med J 2009, 85:84-90.
15. Ruidavets J.B., Bongard V., Dallongeville J., Arveiler D., Ducimetière P., Perret B., et al. High consumptions of grain, fish, dairy products and combinations ofthese are associated with a low prevalence of metabolic syndrome. JEpidemiol Community Health 2007, 61:810-817.
16. Lara J.J., Economou M., Wallace A.M., Rumley A., Lowe G., Slater C., et al. Benefits of salmon eating on traditional and novel vascular risk factors in young, non-obese healthy subjects. Atherosclerosis 2007, 193:213-221.
17. Grundy S.M., Cleeman J.I., Merz C.N.B., Brewer H.B., Clark L.T., Hunninghake D.B., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004, 110:227-239.
18. Mensik R.P., Zock P.L., Kester A.D.M., Katan M.B. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteis: a meta-analysis of 60 controlled trials. Am J Clin Nutr 2003, 77:1146-1155.
19. Harris W.S., Mozaffarian D., Rimm E., Kris-Etherton P., Rudel L.L., Appel L.J., et al. Omega-6 fatty acids and risk for cardiovascular disease. A science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism: Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 2009, 119:902-907.
20. Zuliani G., Galvani M., Leitersdorf E., Volpato S., Cavalieri M., Fellin R. The role of polyunsaturated fatty acids (PUFA) in the treatment of dyslipidemias. Curr Pharmac Design 2009, 15:4087-4093.
21. Belalcazar L.M., Reboussin D.M., Haffner S.M., Reeves R.S., Schwenke D.C., Hoogeveen R.C., et al. Marine omega-3 fatty acid intake: associations with cardiometabolic risk and response to weight loss intervention in the Look AHEAD (Action for Health in Diabetes) study. Diabetes Care 2009, 33:197-199.
22. Crawford M., Galli C., Visioli F., Renaud S., Simopoulos A.P., Spector A.A. Role of plant-derived omega-3 fatty acids in human nutrition. Ann Nutr Metab 2000, 44:263-265.
23. Mangas-Cruz M.A., Fernandez-Moyano A., Albi T., Guinda A., Relimpio F., Lanzón A., et al. Effects of minor constituents (non-glyceride compounds) of virgin oil in plasma lipid concentrations in male Wistar rats. Clin Nutr 2001, 20:211-215.
24. Berbert A.A., Kondo C.R.M., Almendra C.L., Matsuo T., Dichi I. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis. Nutrition 2005, 21:131-136.
25. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752.
26. Haffner S.M. Insulin resistance, inflammation and the prediabetic state. Am J Cardiol 2003, 92:18J-26J.
27. Flecha B.G., Llesuy S., Boveris A. Hydroperoxide-initiated chemiluminescence: an assay for oxidative stress in biopsies of heart, liver, and muscle. Free Radic Biol Med 1991, 10:93-100.
28. Simão A.N.C., Dichi J.B., Barbosa D.S., Cecchini R., Dichi I. Influence of uric acid and gammaglutamyltransferase on total antioxidant capacity and oxidative stress in patients with metabolic syndrome. Nutrition 2008, 24:675-681.
29. Witko-Sarsat V., Friedlander M., Capeillère-Blandin C., Nguyen-Khoa T., Nguyen A.T., Zingraff J., et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996, 49:1304-1313.
30. Repetto M., Reides C., Carretero M.L.G., Costa M., Griemberg G., Llesuy S. Oxidative stress in blood of HIV infected patients. Clin Chim Acta 1996, 255:107-117.
31. Liem A.H., van de Woestijne A.P., Roeters van Lennep H.W., Zwinderman A.H., van der Steeg W.A., Jukema J.W. ApoB/A1 and LDL-C/HDL-C and the prediction of cardiovascular risk in statin-treated patients. Curr Med Res Opin 2008, 24:359-364.
32. Simão A.N., Godeny P., Lozovoy M.A., Dichi J.B., Dichi I. Effect of n-3 fatty acids in glycemic and lipid profiles, oxidative stress and total antioxidant capacity in patients with metabolic syndrome. Arq Bras Endocrinol Metabol 2010, 54:463-469.
33. Saito Y., Yokoyama M., Origasa H., Matsusaki M., Matsuzawa Y., Ishikawa Y., et al. JELIS investigators Japan. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: subanalysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS). Atherosclerosis 2008, 200:135-140.
34. Simão A.N.C., Lozovoy M.A.B., Dichi I. Effect of soy product kinako and fish oil on serum lipids and glucose metabolism in women with metabolic syndrome. Nutrition 2014, 30:112-115.
35. Saravanan P., Davidson N.C., Schmidt E., Calder P.C. Cardiovascular effects of marine omega-3 fatty acids. Lancet 2010, 376:540-550.
36. De Caterina R., Madonna R., Bertolotto A., Schmidt E.B. N-3 fatty acids in the treatment of diabetic patients: Biological rationale and clinical data. Diabetes Care 2007, 30:1012-1026.
37. Oikawa S., Yokoyama M., Origasa H., Matsusaki M., Matsuzawa Y., Saito Y., et al. Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: subanalysis of the Japan Lipid Intervention Study (JELIS). Atherosclerosis 2009, 206:535-539. For the Jelis Investigators, Japan.
38. Daamsgard C.T., Frokiaer H., Andersen A.D., Lauritzen L. Fish oil combination with high or low intakes of linoleic acid lowers plasma triacylglycerols but does not affect other cardiovascular risk markers in healthy men. J Nutr 2008, 138:1061-1066.
39. Simão A.N.C., Lovozoy M.A.B., Bahls L.D., Morimoto H.K., Simão T.N.C., Matsuo T., et al. Blood pressure decrease with ingestion of a soy product (kinako) or fish oil in women with metabolic syndrome: role of adiponectin and nitric oxide. Br J Nutr 2012, 108:1435-1442.
40. Covas M.I., Nyyssönen K., Poulsen H.E., Kaikkonen J., Zunft H.J.F., Kieseweter H., et al. The effects of polyphenols in olive oil on heart disease risk factors. A randomized trial. Ann Intern Med 2006, 145:333-341.
41. Roberts C.K., Sindhu K.K. Oxidative stress and metabolic syndrome. Life Sci 2009, 84:705-712.
42. Schmidt S., Stahl F., Mutz K.O., Scheper T., Hahn A., Schuchardt J.P. Transcriptome-based identification of antioxidant gene expression after fish oil supplementation in normo- and dyslipidemic men. Nutr Metab 2012, 9:1-13.
43. McAnulty S.R., Nieman D.C., Fox-Rabinovich M., Duran V., McAnulty L.S., Henson D.A., et al. Effect of n-3 fatty acids and antioxidants on oxidative stress after exercise. Med Sci Sports Exerc 2010, 42:1704-1711.
44. Melo J.U., Santos J.M., Kimura O.S., Campos Júnior M.M., Melo R.B., Vasconcelos P.R.L. Effects of fatty acids on liver regeneration in rats. Rev Col Bras Cir 2010, 37:351-357.
45. Al Gubory K.H. Mitochondria: omega-3 in the route of mitochondrial reactive oxygen species. Int J Biochem Cell Biol 2012, 44:1569-1573.
46. Crnkovic S., Riederer M., Lechleitner M., Hallström A., Malli R., Graier W.F., et al. Docosahexaenoic acid-induced unfolder protein response, cell cycle arrest, and apoptosis in vascular smooth muscle cells are triggered by Ca2+-dependent induction of oxidative stress. Free Rad Biol Med 2012, 52:1786-1795.
47. Shi X.Y., Hou F.F., Niu H.X., Wang G.B., Xie D., Guo Z.M., et al. Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal adenine dinucleotide phosphase oxidase. Endocrinology 2008, 149:1829-1839.
48. Fitó M., Covas M.I., Lamuela-Raventós R.M., Vila J., Torrents J., de la Torre C., et al. Protective effect of olive oil and its phenolic compounds against low density lipoprotein oxidation. Lipids 2000, 35:633-638.
49. Visioli F., Bellomo G., Modedoro G., Galli C. Low density lipoprotein oxidation is inhibited invitro by olive oil constituents. Atherosclerosis 1995, 117:25-32.
50. Zamora-Ros R., Serafini M., Estruch R., Lamuela-Raventós R.M., Martinéz-González M.A., Salas-Salvadó J., et al. Mediterranean diet and non enzymatic antioxidant capacity in the PREDIMED study: evidence for a mechanism of antioxidant tuning. Nutr Metab Cardiovasc Dis 2013, 23:1167-1174.
51. Samaniego-Sánchez C., Quesada-Granados J.J., Sánchez-Navarro M.R., López-García de la Serrana H., López-Martínez M.C. Antioxidant capacity of blood after extra-virgin olive oil intake in humans volunteers. Olive and olive oil in health and disease prevention 2010, 915-924. Elsevier B.V., Amsterdam, Netherlands.
52. Konstantinidou V., Covas M.I., Muñz-Aguayo D., Khymenets O., de la Torre R., Saez G., et al. Invivo nutrigenomic effects of virgin olive oil polyphenols within the frame of the Mediterranean diet: a randomized controlled trial. FASEB J 2010, 24:2546-2557.
53. Castañer O., Covas M.I., Khymenets O., Nyyssonen K., Konstantinidou V., Zunft H.F., et al. Protection of LDL from oxidation by olive oil polyphenols is associated with a down regulation of CD40-ligand expression and its downstream products invivo in humans. Am J Clin Nutr 2012, 95:1238-1244.
54. Kesavulu M.M., Rao B.K., Giri R., Vijaya J., Subramanyam G., Apparao C. Lipid peroxidation and antioxidant enzyme status in type 2 diabetes with coronary heart disease. Diab Res Clin Pract 2001, 53:33-39.
55. Skalicky J., Muzakova V., Kandar R., Meloun M., Rousar T., Palicka V. Evaluation of oxidative stress and inflammation in obese adults with metabolic syndrome. Clin Chem Lab Med 2008, 46:499-505.
56. Simão A.N., Lozovoy M.A., Dichi I. The uric acid metabolism pathway as a therapeutic target in hyperuricemia related to metabolic syndrome. Expert Opin Ther Targets 2012, 16:1175-1187.